Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
Healthy Volunteers
ID07226193

Pulse Arrival Time as an Alternative Biomarker to Detect Lower-Extremity Peripheral Artery Disease

Led by University of Nebraska · Updated on 2026-05-19

60

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating segmental pulse arrival time (PAT) as a possible new biomarker to detect lower-extremity peripheral artery disease (PAD) and to study how local skin heating, foot elevation, and age affect PAT. The study includes adults aged 19 or older, with or without PAD. It aims to determine if PAT can predict PAD compared to the standard ankle-brachial index (ABI) and how these factors influence the measurements. Participants will attend a single laboratory visit where descriptive measurements like height, weight, body fat, age, and sex are recorded. They will rest lying down for 20 minutes before having either ABI or PAT measured first, then the other test after 10 minutes of rest. PAT is measured using a special device with sensors on the fingers and toes that monitor heart and blood flow signals while the skin temperature is adjusted and the feet are elevated. ABI uses blood pressure cuffs and Doppler ultrasound to measure blood pressure in the arms and legs. After these tests, participants complete a 6-minute walking test to assess exercise capacity. During the visit, blood pressure is taken at various stages, and thermal images of the fingers and toes are captured to record skin temperature changes. The study lasts about 2.5 hours with no follow-up visits. Researchers compare PAT results with ABI and walking test outcomes to evaluate PAT's accuracy in detecting PAD and related walking difficulties. Safety is monitored throughout the visit, and participants' usual care continues unaffected.

CONDITIONS

Brief Title

Detecting Peripheral Artery Disease With the Pulse

Who Can Participate

Age: 19Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be able to provide written informed consent
  • Be 19 years of age or older
  • Have or not have a diagnosis of peripheral artery disease
Not Eligible

You will not qualify if you...

  • Have a current or previous aortic aneurysm with or without previous intervention
  • Have had previous revascularization surgeries of the legs or aorta
  • Have walking impairments not caused by lower-limb ischemia
  • Have gangrene or ulcers of the toes or feet
  • Be currently pregnant or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Approximately 2.5 hours

Participants attend a single laboratory visit where segmental pulse arrival times are assessed with an investigational device, ankle-brachial index measurements are performed, and a 6-minute walking test is conducted to evaluate lower-extremity peripheral artery disease.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

University of Nebraska at Omaha Health Science Collaborative

Omaha, Nebraska, United States, 68182

Actively Recruiting

Loading map...

Research Team

C

Cody P Anderson

G

Gwenael Layec, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Real-World Clinical Evaluation of the Shockwave Intravascula...

Peripheral Artery Disease (PAD)

Actively Recruiting

1 location

EXercise ACTivity to Improve Mobility, Active Behavior and Q...

Chronic Kidney Disease Stage 3 and 4

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here